key: cord-0718963-9if20963 authors: Plebani, Alessandro; Meini, Antonella; Cattalini, Marco; Lougaris, Vassilios; Bugatti, Antonella; Caccuri, Francesca; Caruso, Arnaldo title: Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children date: 2020-10-16 journal: Clin Immunol DOI: 10.1016/j.clim.2020.108613 sha: 6a8480a6cd72a58847f323e42ca08e0bf303aa69 doc_id: 718963 cord_uid: 9if20963 • Mycoplasma pneumoniae co-infection in pediatric patients with SARS-CoV-2 associated Kawasaki-like disease, may contribute to a more severe clinical course. children presenting as a hyperinflammatory syndrome with multiorgan involvement resembling Kawasaki disease (KD) and/or Kawasaki shock syndrome (KSS) [3, 4] . Upon the first description of this SARS-CoV-2 related manifestation in children, follow-up studies suggested that this Multisystem Inflammatory Syndrome in Children (MIS-C) related to SARS-COV-2 infection may present a continuum of clinical findings, ranging from Kawasaki-like disease to myocarditis [5] [6] . We identified nine previously healthy children (six males and three females) with a mean age of 8.9 years (range 13 months-14 years), eight of caucasian and one of african origin, admitted to the Pediatric Clinic of University of Brescia-ASST Spedali Civili, with Kawasaki/KSS-like disease. This incidence was 5-fold superior to what we observed in the 2015-2019 period. Eight children had known family exposure to SARS-CoV-2. Nasopharyngeal swabs were negative in all patients, while IgG antibodies against SARS-CoV-2, were detected by Western Blot in seven out the eight children tested. Demographics, clinical and imaging findings, treatment and outcome for this cohort of nine children are shown in Table 1 . Clinical symptoms were similar for all patients and included unrelenting fever, skin rash, oral mucositis, conjunctivitis, and peripheral edema. Gastrointestinal symptoms (such as diarrhea, vomiting, abdominal pain), and severe dyspnea were present in four and two patients respectively. Seven out of nine patients developed a vasoplegic shock refractory to volume resuscitation with three patients requiring vasopressors for haemodynamic support. Development of ascitic effusions occurred in three patients whereas pericardial and pleural effusions in two. Laboratory evidence of inflammation included elevated concentrations of C-reactive protein, procalcitonin, ferritin, and D-dimer. Hypoalbuminemia and hyponatremia were present in eight out of nine patients. No pathological organisms were isolated from biological specimens. Four out of these nine children (Pts 1, 3, 8, 9) showed a remarkable increase of IgM serum levels against Mycoplasma pneumoniae (MP) suggestive of a primary infection. A single patient (Pt.9) J o u r n a l P r e -p r o o f was tested twice and showed a progressive increase of the IgM titers during a 7 day-period (Table 1 ). These four patients presented a more severe clinical course of the disease with rapid deterioration in terms of vasoplegic shock and general clinical conditions. Of note, their mean age was 9.0 years, an age group typically affected by Mycoplsma pneumoniae infection. For all patients, antibody testing both for SARS-CoV-2 and Mycoplasma infection was performed on the same blood sample drawn within ten days from the symptoms' onset. (HLH) [10] [11] . The two original studies on the pediatric COVID-19-related KD did not include sierology testing for Mycoplasma [3] [4] . Viral infections in children on the other hand are widely accepted as potential triggers for a cytokine storm leading to the development of Multisystem Inflammatory Syndrome in Children (MIS-C), and this has also been reported in children with COVID-19 in a minority of cases [3] [4] [5] 12] . Our study would like to emphasize the importance of testing for Mycoplasma in severely ill children with KD/KSS-like disease and/or MIS-C, and underline that the dual infectious pro-inflammatory trigger, ie SARS-CoV-2 and Mycoplasma pneumoniae, may cause rapid clinic deterioration in affected children. Development of child immunity in the context of COVID-19 pandemic COVID-19 -Considerations for the paediatric rheumatologist Hyperinflammatory shock in children during COVID-19 pandemic An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study SARS-CoV-2 infections in children and young people Mycoplasma pneumoniae infection associated with Kawasaki disease Evidence of acute Mycoplasma infection in a patient with incomplete and atypical kawasaki disease: a case report Mycoplasma pneumoniae infection in patients with Kawasaki disease Cytokine profiles in Mycoplasma pneumoniae infection-associated hemophagocytic lymphohistiocytosis Adult Onset Still's Disease Associated with Mycoplasma pneumoniae Infection and Hemophagocytic Lymphohistiocytosis New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team. Multisystem Inflammatory Syndrome in Children in New York State We would like to thank the patients, the patients' families and the nurses for all their efforts. Several of the authors are members of the European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (project identification No. 739543).